SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-376497
Filing Date
2013-09-24
Accepted
2013-09-24 17:10:54
Documents
3
Period of Report
2013-09-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d602693d8k.htm 8-K 19508
2 EX-99.1 d602693dex991.htm EX-99.1 25280
3 GRAPHIC g602693g41z91.jpg GRAPHIC 8451
  Complete submission text file 0001193125-13-376497.txt   57673
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28298 | Film No.: 131112790
SIC: 2836 Biological Products, (No Diagnostic Substances)